Suzhou Sunmed

Suzhou Sunmed Biotech is a precision medicine company specializing in liquid biopsy and cancer diagnostics. Founded in 2016 and based in the Suzhou Industrial Park, the company has developed the proprietary CytoSorter® platform, which utilizes microfluidic chip technology for the high-purity enrichment and identification of Circulating Tumor Cells (CTCs). This platform enables non-invasive monitoring of tumor dynamics, early screening, and personalized treatment guidance for a variety of solid tumors, including lung, breast, and prostate cancers. Sunmed Biotech's products are widely used in clinical settings across China, supported by a robust R&D pipeline and partnerships with leading medical institutions. The company is backed by prominent investors such as SoftBank China Venture Capital and Northern Light Venture Capital.